FORM 10-KSB
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

[ ] 15,ANNUAL REPORT UNDER SECTION 13 OR 15(D) OF
THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended: August 31, 2006
OR
[ ]15,TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
For the transition period from

Commission file number:

DULCIN IZMIR CORPORATION
     (Exact name of Small Business Issuer in its charter)


             FLORIDA                         20-2710793
  (State or other jurisdiction of           (I.R.S. Employer
    incorporation or organization           Identification No.)

         P. O. Box 331916
         Miami, FL                                  33233-1916
 (Address of principal executive offices)            (Zip Code)

Registrant's Telephone number, including area code:  (305) 586-4167


Securities registered pursuant to Section 12(b) of the Act:       None
Securities registered pursuant to Section 12(g) of the Act:
   Common Stock, $.01 par value

Check whether the issuer is not required to file reports pursuant to
Section 13 or 15(d) of the Exchange Act   [   ]

Check whether the Corporation (1) has filed all reports required to be
filed by Section 13 or 15(d) of the Securities Exchange Act during the
preceding 12 months (or such shorter period that the Corporation was
required to file such reports), and (2) has been subject to such filing
requirements for at least the past 90 days.
Yes    __x__          No  _____

Check if there is no disclosure of delinquent filers in response to
Item 405 of Regulation S-B is not contained in this form, and no
disclosure will be contained, to the best of Corporation's knowledge,
in definitive proxy or information statements incorporated by reference
in Part III of this Form 10-KSB or any amendment to this Form 10-KSB.
[ x ]

Indicate by check mark whether the registrant is a shell company (as
defined in Rule 12b-2 of the Exchange Act).  Yes [  ]   No [x]

Dulcin Izmir's revenues for its most recent fiscal year were $0.00.  As
of August 31, 2006, there was no market value of Dulcin Izmir's voting
$.000l par value common stock.

<PAGE>2

The number of shares outstanding of Dulcin Izmir's only class of common
stock, as of August 31, 2006 was 12,037,500 shares of its $.0001 par
value common stock.

No documents are incorporated into the text by reference.

Transitional Small Business Disclosure Format (check one)
 Yes                No     x
     --------          --------





<PAGE>3
PART I
ITEM 1.    BUSINESS

Dulcin Izmir Corporation is a development stage company.  We are a
Florida corporation, formed on April 11, 2005.

Dulcin Izmir had entered into a memorandum of understanding on August
15, 2005 with Deleo Ltd., a Delaware Corporation.  Deleo Ltd owns a
technology called Catalytically Enhanced Engine Fuel Systems.  Under
the MOU, Dulcin Izmir was to purchase up to a 70% equity interest in
Blue Sky International, Ltd.  Deleo Ltd. has granted Blue Sky an
exclusive, worldwide, non-royalty bearing license to manufacture and
market Deleo's engine devices.  Dulcin Izmir had been unable to
successfully complete a definitive material agreement incorporating the
terms of the MOU and formally terminated further negotiations with Blue
Sky on August 18, 2006.  As a result, Dulcin Izmir has been actively
pursuing alternative business opportunities.

Fairgrief Memorandum of Understanding.  On August 22, 2006, we entered
into a memorandum of understanding with Kevin Fairgrief, to create and
fund our subsidiary, Lifespan Health Sciences, Inc. which was
incorporated on August 31 2006.  Lifespan is presently owned 53% by
Dulcin and 47% by Fairgrief, with the eventual ownership changing to
62.1% by Dulcin when and if the fundraising for Lifespan is completed.
Fairgrief agreed to transfer all of his rights, interest and knowledge
in his treatment program for numerous human diseases and conditions to
Lifespan in exchange for 11,000 shares of Lifespan common stock.
Dulcin Izmir will fund Lifespan specifically to have Fairgrief's
treatment programs implemented on a large scale.

If Dulcin does not fund Lifespan with $2,000,000 by March 31, 2008,
Fairgrief can buy Lifespan at a sum equal to the amount invested by
Dulcin plus 5% per annum.

By December 31, 2006, Dulcin must invest $250,000 in Lifespan, and an
additional $150,000 by March 31, 2007, in order to maintain its initial
percentage ownership.  Dulcin is required to invest an additional
$1,600,000 in Lifespan by March 31, 2008.  At reaching this milestone,
Dulcin's equity will be 57.7%.  Dulcin is required to invest an
additional $3,000,000 by December 31, 2009 at which time the equity
will be 62.1% for Dulcin.  There is a clause whereby Fairgrief will own
the reciprocal percentages, and if his equity falls below those
percentages, Dulcin will transfer sufficient shares to him.

The MOU also has provisions for compensation to Fairgrief in four
stages.  In the first stage which commenced on July 1, 2006, Fairgrief
will be paid $6,000 per month, in phase 2 $7,000 per month, and in
phases 3 and 4, if Lifespan becomes profitable, $8,000 and $10,000,
respectively.  As of August 31, 2006, Fairgrief was paid a total of
$12,000 prior to the incorporation of Lifespan for the two months then
ended.



<PAGE>4

Initially Lifespan will create a website and will open a treatment
clinic in Palm Springs, CA, where Fairgrief's knowledge, experience and
efforts will be tested and documented.  Once Lifespan's program has
been clinically confirmed and treatment protocols have been developed,
Lifespan plans to open other clinics in California.

After years of testing, Fairgrief's test results show that many foods
produce different negative reactions in the human body, leading to
diseases of different degrees.  Lifespan believes that these foods are
different and unique for everyone, although there are patterns visible
in testing family members.  Experience has reflected a wide array of
chronic problems, symptoms and disease that completely resolve once the
offending foods are removed and the body's digestive tract is allowed
to heal.

Lifespan's program for treating patients starts with the patient taking
a five pathway serum blood test that will disclose which foods,
additives and beverages cause a negative damaging response from the
immune system.  The resulting negative response in most cases is
primarily inflammation.  Chronic inflammation, if left untreated, can
lead to a number of serious conditions.  The testing of each patient
allows for an individually tailored program of eating foods that do not
cause harm or affect the body's complex system in a negative way.
Almost all auto-immune and chronic diseases are relieved when the
patient follows the program which requires the patient to eat from a
specific list of foods, in a 4-5 day rotation to eliminate the chance
of creating new intolerances.  There are numerous herbal supplements
added to aid in healing the damaged tissue.  There are also other
diagnostics that will allow a thorough treatment depending on each
patient profile and symptoms.

These individual eating and supplement programs require approx four to
six months of careful food and supplement ingestion after which
patients may slowly add new foods back into their diets.

This treatment program has been tested in individuals with diseases
like fibromyalgia, emotional/mood disorders, insomnia, under/over
weight problems, blood pressure and virtually all diseases with an
inflammatory origin.  Lifespan believes that by standardizing the
process, it will be able to help a larger amount of patients that
modern traditional medicine to date has been ineffective in treating.

Fairgrief believes that the diseases mentioned above are widespread,
and are a tremendous drain on the world health care system.  Dulcin
Izmir thinks there is an opportunity to establish a large network of
clinics that can effectively treat these diseases.


ITEM 2.  PROPERTIES.

We signed a one year lease renewal for office space in Miami, Florida
commencing on August 1, 2006, for a monthly rental of $963.




<PAGE>5

ITEM 3.  LEGAL PROCEEDINGS.

Dulcin Izmir is not involved in any legal proceedings at this date.


ITEM 4.  SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS.

During the last quarter of the fiscal year ended August 31, 2006, no
matters were submitted to a vote of Dulcin Izmir Corporation security
holders, through the solicitation of proxies.



<PAGE>6

PART II

ITEM 5.  MARKET FOR CORPORATION'S COMMON EQUITY AND RELATED STOCKHOLDER
MATTERS

Market Information.  Dulcin Izmir has not yet begun trading publicly on
the pink sheets or the NASD Over the Counter Bulletin Board.

Dulcin Izmir has never paid any cash dividends nor does it intend, at
this time, to make any cash distributions to its shareholders as
dividends in the near future.

As of August 31, 2006, the number of holders of Dulcin Izmir's common
stock is 18.


ITEM 6.   MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
AND RESULTS OF OPERATIONS.

Trends and Uncertainties.

Dulcin Izmir is in the development stage, has not commenced operations
and has sustained a loss to date.  We have just recently created a
subsidiary and changed our business plan.

Financing Activities.

For the year ended August 31, 2006, Dulcin Izmir received proceeds of
$241,300 from sale of common stock net of offering costs in 2005.
Additionally, Dulcin Izmir had a decrease in advances - related party
of $3,885. As a result, Dulcin Izmir had net cash provided by financing
activities of $245,185 for the year ended August 31, 2006.

For the period from April 11, 2005 (inception) to August 31, 2005,
Dulcin Izmir received proceeds from the sale of common stock of
$35,700.  Additionally, Dulcin Izmir had an increase in an advance of
$3,885 to an affiliated party to pay for research and development costs
for Blue Sky International Inc.  As a result, Dulcin Izmir had net cash
provided by financing activities of $31,815 for the period from April
11, 2005 (inception) to August 31, 2005.
Investing Activities.

For the year ended August 31, 2006, Dulcin Izmir had an increase in
equipment of $1,675 and a decrease in advances of $6,906.  As a result
Dulcin Izmir had net cash provided by investing activities of $5,231
for the year ended August 31, 2006.

For the period from inception to August 31, 2005, Dulcin Izmir paid
advances of $6,906 to non-affiliates.


<PAGE>7

Results of Operations.

For the year ended August 31, 2006 and the period from April 11, 2005
(inception) to August 31, 2005, Dulcin Izmir did not receive any
revenues.  For the year ended August 31, 2006, Dulcin Izmir had general
and administrative expenses of $130,056.  Comparatively, Dulcin Izmir
had general administrative expenses of only $17,036 for the period from
April 11, 2005 (inception) to August 31, 2005.  The increase in general
and administrative expenses was mainly due to expenses relating to the
stock registration which was declared effective on March 31, 2006.
Additionally, due to the agreement with Blue Sky International, Inc.,
Dulcin Izmir had an increase in research and development costs of
$47,890 for the year ended August 31, 2006 compared to $14,862 for the
period from April 11, 2005 (inception) to August 31, 2005.

On August 11, 2006, we loaned Reven Pharma Corp. $50,000.  Since the
loan was unsecured and not repaid as of August 31, 2006, or
subsequently, we had the alternative option of collateralizing the loan
with common stock of Reven or applying it towards an interest in an
application that Reven was developing.

Reven has not provided us with any financial information, nor has it
guaranteed the loan.  Therefore, we decided to impair the full amount
of the loan as of August 31, 2006, based on the present inability of
Reven to repay it, or provide sufficient information with which to
evaluate its collectibility or eventual recoverability.

Dulcin Izmir had a net loss of $(227,946) for the year ended August 31,
2006 compared to $(31,989) for the period from April 11, 2005
(inception) to August 31, 2005 due to the reasons discussed above.

Plan of Operation.   Our ability to continue in existence is dependent
on our ability to develop additional sources of capital
<TABLE>
Milestones:                          Steps                     Timeline

                                   <c>                       <c>
1. Develop additional        Prepare Business Plan           4-6 months
   sources of capital

2. Set up marketing plan     Create website                   2 months

3. Open treatment clinic     Confirm clinically              4-6 months
                             Develop treatment protocols     4-6 months
</TABLE>
Milestone 1 needs to be completed before we pursue Milestone 2.  No one
milestone needs to be complete to pursue Milestone 3.

Going Concern.   The accompanying financial statements have been
prepared assuming that Dulcin Izmir will continue as a going concern.
Going concern contemplates the realization of assets and the
satisfaction of liabilities in the normal course of business over a
reasonable length of time.  Dulcin Izmir is in the development stage
and has incurred ($259,844) in losses since inception and has negative

<PAGE>8

cash flows from operations.  The future of Dulcin Izmir is dependent
upon our ability to reach our milestones, obtain additional equity
financing and upon future successful development and marketing of
Dulcin Izmir's services.

Failure to reach the milestones discussed above or secure additional
financing, if any, may result in Dulcin Izmir's inability to continue
as a going concern.

Recent Accounting Pronouncements.

Interpretation No. 46 (FIN 46) (R)

Effective December 2003, The Financial Accounting Standards Board
revised Fin 46 which required certain variable interest entities to be
consolidated by the primary beneficiary of the entity if the equity
investors in the entity did not have the characteristics of a
continuing financial interest or did not have sufficient equity at risk
for the entity to finance its activities without additional
subordinated financial support from other parties, the determination to
be made on the date an enterprise becomes involved with an entity.

SFAS 123 (R)

In December 2004, the FASB issued Statement of Financial Accounting
Standards ("SFAS") No. 123 (revised 2004), Share-Based Payment
("SFAS No. 123-R"). SFAS No.123-R is a revision of SFAS No. 123, as
amended, Accounting for Stock-Based Compensation, and supersedes
Accounting Principles Board Opinion No. 25, Accounting for Stock Issued
to Employees. SFAS No.123-R eliminates the alternative to use the
intrinsic value method of accounting that was provided in SFAS No. 123,
which generally resulted in no compensation expense recorded in the
financial statements related to the issuance of equity awards to
employees. SFAS No. 123-R requires that the cost resulting from all
share-based payment transactions be recognized in the financial
statements. SFAS No. 123-R establishes fair value as the measurement
objective in accounting for share-based payment arrangements and
requires all companies to apply a fair-value-based measurement method
in accounting for generally all share-based payment transactions with
employees commencing in 2006.

The adoption of these new Statements is not expected to have a material
effect on the Company's financial position, results of operations, and
cash flows in future periods.


ITEM 7. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

Financial Statements

The response to this item is being submitted as a separate section of
this report beginning on page 14.


<PAGE>9

ITEM 8.  CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING
AND FINANCIAL DISCLOSURE

None


ITEM 8A CONTROLS AND PROCEDURES

Controls and Procedures.  Maria Camila Maz, the Chief Executive Officer
and the Chief Financial Officer of the Corporation has made an
evaluation of the disclosure controls and procedures relating to the
annual report on Form 10KSB for the year ended August 31, 2006 as filed
with the Securities and Exchange Commission and has judged such
controls and procedures to be effective as of August 31, 2006 (the
evaluation date).

Dulcin Izmir's internal controls were compromised by its bookkeeper
during the current year only, wherein the bookkeeper intentionally paid
herself $11,000 more than she had earned using pre-signed checks. This
amount was subsequently reduced to $9,000 by an offset of time she had
earned, and the reduced balance was repaid in full in July 2006, by
which date she was terminated.  There was no resulting effect on
financial position or results of operations as of August 31, 2006, and
for the year then ended.  A change in internal controls to preclude the
issuance of any further pre-signed checks was subsequently implemented
by management.

There have not been any other significant changes in the internal
controls of Dulcin Izmir or other factors that could significantly
affect internal controls relating to Dulcin Izmir since the evaluation
date.



<PAGE>10
PART III

ITEM 9.    DIRECTORS AND EXECUTIVE OFFICERS OF THE CORPORATION

Our bylaws provide that the number of directors who shall constitute
the whole board shall be such number as the board of directors shall at
the time have designated.  We confirm that the number of authorized
directors has been set at three pursuant to our bylaws.  Each director
shall be selected for a term of one year and until his successor is
elected and qualified.  Vacancies are filled by a majority vote of the
remaining directors then in office with the successor elected for the
unexpired term and until the successor is elected and qualified.

The directors and executive officers are as follows:
<TABLE>
NAME                                 POSITIONS HELD          SINCE

                                  <c>                      <c>
Maria Camila Maz, age 38             President/CEO/Director  Inception
                                                             To present
</TABLE>

BUSINESS EXPERIENCE OF OFFICERS AND DIRECTORS
---------------------------------------------
Maria Camila Maz.   Ms. Maz has been an officer and director of Dulcin
Izmir since inception.  From 2002 to present, Ms. Maz has been the
president of Prosper Financial, Inc., a management company that
currently has a contract with Strategic Rare Earth Metals Inc., a
reporting company and a company that mines, processes and distributes
various granites and produces and distributes Rare Earth metals and
alloys.  In this role, Ms. Maz acts as secretary and treasurer of
Strategic Rare Earth Metals Inc.  From May 2004 to March 2005, Ms. Maz
was president and director of FUSA Capital Corporation, a reporting
company engaged in ownership, development and marketing video and audio
search engine technology.  From 2000-2002, Ms. Maz was executive
assistant and investment analyst for Auron 2000, Inc., a company
engaged in consulting and management of companies in several industries
from biotech to technology and internet.  Ms. Maz received a Bachelor
of Business Administration with areas of concentration in marketing and
finances from the Universidad de los Andes in 1993.

Indemnification.  Dulcin Izmir shall indemnify to the fullest extent
permitted by, and in the manner permissible under the laws of the State
of Florida, any person made, or threatened to be made, a party to an
action or proceeding, whether criminal, civil, administrative or
investigative, by reason of the fact that he is or was a director or
officer of Dulcin Izmir, or served any other enterprise as director,
officer or employee at the request of Dulcin Izmir.  The board of
directors, in its discretion, shall have the power on behalf of Dulcin
Izmir to indemnify any person, other than a director or officer, made a
party to any action, suit or proceeding by reason of the fact that
he/she is or was an employee of Dulcin Izmir.

Insofar as indemnification for liabilities arising under the Act may be
permitted to directors, officers and controlling persons of Dulcin
Izmir, Dulcin Izmir has been advised that in the opinion of the
Securities and Exchange Commission such indemnification is against

<PAGE>11

public policy as expressed in the Act and is, therefore, unenforceable.
In the event that a claim for indemnification against such liabilities
(other than the payment by Dulcin Izmir of expenses incurred or paid by
a director, officer or controlling person of Dulcin Izmir in the
successful defense of any action, suit or proceedings) is asserted by
such director, officer, or controlling person in connection with any
securities being registered, Dulcin Izmir will, unless in the opinion
of its counsel the matter has been settled by controlling precedent,
submit to a court of appropriate jurisdiction the question whether such
indemnification by it is against public policy as expressed in the Act
and will be governed by the final adjudication of such issues.

INDEMNIFICATION OF OFFICERS OR PERSONS CONTROLLING THE CORPORATION FOR
LIABILITIES ARISING UNDER THE SECURITIES ACT OF 1933, IS HELD TO BE
AGAINST PUBLIC POLICY BY THE SECURITIES AND EXCHANGE COMMISSION AND IS
THEREFORE UNENFORCEABLE.


ITEM 10.  EXECUTIVE COMPENSATION

Executive Compensation.

Maria Camila Maz devotes approximately 50% of her time to Dulcin Izmir
Corporation and our subsidiary's affairs.

Pursuant to a consulting agreement, Dulcin Izmir pays Prosper Financial
Inc. $4,000 per month for management services, preparing a Business
Plan, raising capital etc.  Ms. Maz is the president and controlling
shareholder of Prosper.   To date, Prosper has received $48,000
pursuant to the consulting agreement.

We do not have any standard arrangements by which directors are
compensated for any services provided as a director.  No cash has been
paid to the directors in their capacity as such.

ITEM 11.   SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND
MANAGEMENT

The following table sets forth, as of October 31, 2006, the number and
percentage of outstanding shares of Dulcin Izmir Corporation common
stock owned by (i) each person known to us to beneficially own more
than 5% of its outstanding common stock, (ii) each director, (iii) each
named executive officer, and (iv) all officers and directors as a
group.  Additionally, the following table includes shares that the
shareholders have the right to acquire within 60 days.



<PAGE>12

 (I) PERSONS BENEFICIALLY OWNING MORE THAN 5% OF OUTSTANDING COMMON
STOCK
-----------------------------------------------------------------------
<TABLE>
<CAPTION>
Name of Beneficial Owners       Common Stock        Percentage Owned
                              Beneficially Owned

                              <c>                   <c>
Maria Camila Maz
4801 Alhambra Circle
Coral Gables, FL 33146              5,000,000          41.54%

Cadaques S.A.(1)
Avenida Brasil 3031, Apto 102
Montevideo, Uruguay                 1,000,000           8.33%

Gustavo Maz (2)                     1,300,000          10.80%
Cr 5 No. 6-204
Cartagena - Colombia

Costas Michael Takkas               1,000,000           8.31%
2642 Collins Avenue, Apt. 305
Miami, FL 33140

Ricardo Requena                     1,000,000           8.31%
25 de Mayo 444, P2
Montevideo, Uruguay

Stratton S.A.(3)                    1,000,000           8.31%
Carace 524, Apto 701
Montevideo, Uruguay

Directors and Officers,
   as a group                       5,000,000          41.54%
</TABLE>

Based upon 12,037,500 issued and outstanding as of October 31, 2006.
(1)  The beneficial owner of Cadaques S.A. is Mario Rovella, a non-
affiliate.
(2) Gustavo Maz is the father of Maria Camila Maz
(3)The beneficial owner for Stratton S.A. is Manon Lecueder, a non-
affiliate.

ITEM 12.  CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS

Accounts Payable - Related Party

As of August 31, 2006, Prosper Financial, Inc. (Prosper), a corporation
owned by the president of Dulcin Izmir who owns the majority of the
outstanding common stock of Dulcin Izmir was owed $4,237.  Prosper was
paid $48,000 during the year ended August 31, 2006 for management
services and $0 for the prior year.



<PAGE>13

Consulting Agreement - Related Party

A consulting agreement between Prosper and Dulcin, which was signed and
effective on September 1, 2005, includes but is not limited to payment
for services in the amount of $4,000 per month, reimbursement for all
reasonable expenses, and shall be in effect for one year from the
commencement of the agreement.  The agreement can be terminated by
Dulcin, with a 30 day notice.  The agreement was renewed for another
one year term effective on September 1, 2006.


ITEM 13.    EXHIBITS, FINANCIAL STATEMENT SCHEDULES, AND REPORTS ON
FORM 8-K

     (A)    FINANCIAL STATEMENTS AND SCHEDULES

The following financial statements and schedules are filed as part of
this report:

Report of Independent Registered Public Accounting Firm         14
Consolidated Balance Sheet                                      15
Consolidated Statements of Operations                           16
Consolidated Statements of Cash Flows                           17
Consolidated Statement of Stockholders' Equity                  18
Notes to Consolidated Financial Statements                      21

Schedules Omitted:    All schedules other than those shown have been
omitted because they are not applicable, not required, or the required
information is shown in the financial statements or notes thereto.







<PAGE>14
       REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Board of Directors and Stockholders
DULCIN IZMIR CORPORATION
Miami, Florida

We have audited the accompanying consolidated balance sheet of DULCIN
IZMIR CORPORATION (a Florida corporation) as of August 31, 2006, and
the related consolidated statements of operations, stockholders'
equity, and cash flows for the period from April 11, 2005 (inception)
to August 31, 2005, and the year ended August 31, 2006.  These
consolidated financial statements are the responsibility of the
Company's management.  Our responsibility is to express an opinion on
these consolidated financial statements based on our audit.

We conducted our audit in accordance with the standards of the Public
Company Accounting Oversight Board (United States).  Those standards
require that we plan and perform the audit to obtain reasonable
assurance about whether the consolidated financial statements are free
of material misstatement.  The Company has determined that it is not
required to have, nor were we engaged to perform, an audit of its
internal control over financial reporting.  Our audit included
consideration of internal control over financial reporting as a basis
for designing audit procedures that are appropriate in the
circumstances, but not for the purpose of expressing an opinion on the
effectiveness of the Company's internal control over financial
reporting.  Accordingly, we express no such opinion.  An audit also
includes examining, on a test basis, evidence supporting the amounts
and disclosures in the consolidated financial statements, assessing the
accounting principles used and significant estimates made by
management, as well as evaluating the overall financial statement
presentation.  We believe that our audit provides a reasonable basis
for our opinion.

In our opinion, the consolidated financial statements referred to above
present fairly, in all material respects, the financial position of
DULCIN IZMIR CORPORATION as of August 31, 2006, and the results of its
operations and its cash flows for the period from April 11, 2005
(inception) to August 31, 2005, and for the year ended August 31, 2006,
in conformity with accounting principles generally accepted in the
United States of America.

The accompanying consolidated financial statements have been prepared
assuming the Company will continue as a going concern.  As discussed in
Note 1 to the financial statements, the Company is in the development
stage, has not commenced operations, and has sustained a loss to date
that raises substantial doubt about its ability to continue as a going
concern.  Management's plans in regard to these matters are also
described in Note 1.  The consolidated financial statements do not
include any adjustments that might result from the outcome of this
uncertainty.


Braverman International, P.C.
Prescott, Arizona
October 27, 2006



<PAGE>15
DULCIN IZMIR CORPORATION
(A DEVELOPMENT STAGE ENTERPRISE)
CONSOLIDATED BALANCE SHEET
August 31, 2006


ASSETS
                                 ------
  Current Assets
      Cash                                             $    25,334
      Prepaid rent                                             900
      Deposit - rent                                           963
                                                       -----------
     Total Current Assets                                   27,197

  Equipment                                                  1,675
                                                       -----------
                                                       $    28,871
                                                       ===========

LIABILITIES AND STOCKHOLDERS' EQUITY
------------------------------------

 CURRENT LIABILITIES

       Accounts payable                                $     1,455
       Accounts payable - related party                      5,171
                                                       -----------
        Total Current Liabilities                            6,626
                                                       -----------
COMMITMENTS AND CONTINGENCIES

 STOCKHOLDERS' EQUITY

Common stock, par value $.0001, 100,000,000 shares
  authorized, 12,037,500 issued and outstanding              1,204
Paid in capital                                            280,886
(Deficit) accumulated during the development stage        (259,844)
                                                       -----------
 Total Stockholders' Equity                                 22,245
                                                       -----------
                                                       $    28,871
                                                       ===========

  SEE ACCOMPANYING NOTES TO FINANCIAL STATEMENTS



<PAGE>16

DULCIN IZMIR CORPORATION
(A DEVELOPMENT STAGE ENTERPRISE)
CONSOLIDATED STATEMENTS OF OPERATIONS
 <TABLE>
<CAPTION>
                                                                       Cumulative
                                               Year                       from
                                              Ended   April 11, 2005  April 11, 2005
                                             May 31,  (Inception) to  (Inception) to
                                              2006    August 31, 2005 August 31, 2006
                                             -------  --------------- ---------------
   
                                        <c>          <c>              <c>
 REVENUES                                 $        -      $        -      $        -

 EXPENSES
    General and administrative
         Consulting fees                      60,500             600          61,100
         Legal fees                            9,065           5,476          14,541
         Stock registration costs             10,294               -          10,294
         Other                                50,197          10,960          61,157
    Research & development                    47,890          14,862          62,752
    Impairment loss                           50,000               -          50,000
                                          ----------      ----------      ----------

    Total expenses                           227,946          31,898         259,844
                                          ----------      ----------      ----------
 NET (LOSS) FROM OPERATIONS                 (227,946)        (31,898)       (259,844)

BASIC NET (LOSS) PER SHARE                $    (0.02)              *
                                          ==========      ==========

 WEIGHTED AVERAGE NUMBER OF
   COMMON SHARES OUTSTANDING              11,977,292       6,469,600
                                          ==========      ==========
*less than $(.01) per share
</TABLE>


SEE ACCOMPANYING NOTES TO FINANCIAL STATEMENTS


<PAGE>17
DULCIN IZMIR CORPORATION
(A DEVELOPMENT STAGE ENTERPRISE)
CONSOLIDATED STATEMENTS OF CASH FLOWS
<TABLE>
<CAPTION>
                                                                       Cumulative from
                                                         April 11,        April 11,
                                              Year         2005              2005
                                             Ended,   (Inception) to   (Inception) to
                                           August 31,    August 31,       August 31,
                                              2006         2005             2006
                                           ----------  -------------    -------------
<c>                                           <c>           <c>              <c>
OPERATING ACTIVITIES
  Net (loss)                               $ (227,946)   $  (31,898)     $ (259,844)
  Adjustments to reconcile net (loss) to net
      cash provided (used) by operating
      activities:
    Common Stock issued for services                -           600             600
    Contributions to capital                    3,250         1,239           4,489

  Changes in operating assets and liabilities:
    Increase in accounts payable
      - related party                           1,034         4,137           5,171
    Increase/ (decrease) in accounts payable  (19,330)       20,785           1,455
   (Increase) in deposit - rent                  (963)                         (963)
   (Increase) in prepaid rent                    (900)                         (900)
                                            ---------    ----------      ----------
  Total adjustments                           (16,090)       26,761           9,852
                                            ---------    ----------      ----------
     NET CASH (USED) BY OPERATING ACTIVITIES (244,855)       (5,137)       (249,992)
                                            ---------    ----------      ----------
INVESTING ACTIVITIES
    (Increase) in equipment                    (1,675)            -          (1,675)
    (Increase)/ decrease in advances            6,906        (6,906)              -
                                            ---------    ----------      ----------
     NET CASH PROVIDED (USED) BY
       INVESTING ACTIVITIES                     5,231        (6,906)         (1,675)
                                            ---------    ----------      ----------
FINANCING ACTIVITIES
    (Increase)/ decrease in advances
      - related party                           3,885        (3,885)              -
     Proceeds from sale of common stock,
       net of offering costs in 2005          241,300        35,700         277,000
                                            ---------    ----------      ----------
     NET CASH PROVIDED BY FINANCING
       ACTIVITIES                             245,185        31,815         277,000
                                            ---------    ----------      ----------
     NET INCREASE IN CASH                       5,562        19,772          25,334

     CASH, BEGINNING OF PERIOD                 19,772             -               -
                                            ---------    ----------      ----------
     CASH, END OF PERIOD                    $  25,334    $   19,772      $   25,334
                                            =========    ==========      ==========
</TABLE>
SEE ACCOMPANYING NOTES TO FINANCIAL STATEMENTS

<PAGE>18
DULCIN IZMIR CORPORATION
(A Development Stage Company)
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY
<TABLE>
                                                               (Deficit)
                                                              Accumulated    Total
                                                                During       Stock-
                               Common Stock         Paid-in   Development    holders'
                            Shares       Amount     Capital      Stage       Equity
                          ----------   ----------  ---------- ----------   ----------

                          <c>          <c>          <c>          <c>          <c>
Inception, April 11, 2005,
 Stock issued for services
 @ $.0001 per share        6,000,000   $      600  $        -  $        -  $      600

Shares issued June 9, 2005
  for cash at $.05 per
  share                      100,000           10       4,990           -       5,000

Shares issued June 15, 2005
 for cash at $.05 per
 share                       300,000           30      14,970           -      15,000

Shares issued July 20, 2005
 for cash at $.05 per
 share                        74,000            7       3,693           -       3,700

Shares issued August 18, 2005
 for cash at $.05 per
 share                       800,000           80      39,920           -      40,000

Shares issued August 24, 2005
 for cash at $.05 per
 share                       200,000           20       9,980           -      10,000

Stock offering costs               -            -     (38,000)          -     (38,000)

Contributed Capital                -            -       1,239           -       1,239

Net (loss) for period              -            -           -     (31,898)    (31,898)
                          ----------   ----------  ----------  ----------  ----------

Balance, August 31, 2005   7,474,000   $      747  $   36,792  $  (31,898) $    5,641

Shares issued September 8,
2005 for cash at $.05
per share                    126,000           13       6,287                   6,300

Shares issued September 13,
2005 for cash at $.05
per share                  1,000,000          100      49,900                  50,000

Shares issued September 14,
2005 for cash at $.05
per share                    100,000           10       4,990                   5,000

<PAGE>19


Shares issued September 16,
2005 for cash at $.05
per share                    700,000           70      34,930                  35,000

Shares issued September 19,
2005 for cash at $.05
per share                    800,000           80      39,920                  40,000

Shares issued September 20,
2005 for cash at $.05
per share                    300,000           30      14,970                  15,000

Shares issued September 22,
2005 for cash at $.05
per share                    140,000           14       6,986                   7,000


Shares issued September 30,
2005 for cash at $.05
per share                  1,000,000          100      49,900                  50,000

Shares issued October 4,
2005 for cash at $.05
per share                     80,000            8       3,992                   4,000


Shares issued October 26,
2005 for cash at $.05
per share                    280,000           28      13,972                  14,000

Proceeds from 2006 private placement

Shares issued June 29, 2006
  for cash at $.40 per share  12,500            1       4,999                   5,000



<PAGE>20

Shares issued July 26, 2006
  for cash at $.40 per share  25,000            3       9,998                  10,000

Contributed Capital                                     3,250                   3,250

Net (loss) for the year                                          (227,946)   (227,946)
                          ----------   ----------   ---------  ----------  ----------
Balance, August 31, 2006  12,037,500   $    1,204   $ 280,885  $ (259,844) $   22,245
                          ==========   ==========   =========  ==========  ==========
</TABLE>


SEE ACCOMPANYING NOTES TO FINANCIAL STATEMENTS




<PAGE>21
DULCIN IZMIR CORPORATION
(A Development Stage Company)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

History

Dulcin Izmir Corporation (Dulcin, we, our, or us) is in the development
stage as defined in Financial Accounting Standards Board Statement No.
7. We are a Florida corporation, formed on April 11, 2005, to be
initially involved in the conservation of the environment and energy
resources via its equity ownership in Blue Sky International Ltd, (Blue
Sky). This pursuit, to be involved in an initial project to develop a
"hydrocarbon processing device that is universally adaptable to engines
and combustion equipment, was terminated on August 18, 2006 (see note
11).

Our new project as of JULY 1, 2006 is to develop a "treatment program
for numerous human diseases and conditions" and open "treatment
clinics" through its new subsidiary, Lifespan Health Sciences Inc.
(Lifespan). Our fiscal year end is August 31.

Basis of Presentation

On August 22, 2006, we entered into a Memorandum of Understanding (MOU)
with Kevin Fairgrief (Fairgrief), to create and fund Lifespan,
incorporated on August 31, 2006. Lifespan is initially owned 52% by
Dulcin and 48% by Fairgrief, with the eventual ownership changing
to62.1% by Dulcin when and if the fundraising for Lifespan is
completed. The financial statements presented herein are those of
Dulcin consolidated with Lifespan.  As of August 31, 2006, there were
no transactions for Lifespan.

The operations of Blue Sky were abandoned on August 18, 2006, as
further described in note 11.  The results of their operations were not
treated as a loss from discontinued operations since the Company is
still pursuing other research and development activities.  Accordingly,
Blue Sky's operations are included in the consolidated results of
operations for the two years presented.  There were no assets or
liabilities remaining of Blue Sky as of August 31, 2006.

Principles of Consolidation

The consolidated financial statements as of and for the year ended
August 31, 2006, include the accounts of Dulcin, Blue Sky and Lifespan
after elimination of all inter-company accounts and transactions.



<PAGE>22
DULCIN IZMIR CORPORATION
(A Development Stage Company)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

Cash Equivalents

The Company considers all highly liquid investments with the original
maturities of three months or less to be cash equivalents.

Going Concern

The Company's financial statements have been presented on the basis
that it is a going concern, which contemplates the realization of
assets and the satisfaction of liabilities in the normal course of
business. We have sustained operating losses since inception. Our
ability to continue in existence is dependent on our ability to develop
additional sources of capital, and/or to achieve profitable operations.
Management's plan is to initially pursue the sale of equity securities
and eventually to provide the services contemplated by the
incorporation of Lifespan. The accompanying financial statements do not
include any adjustments that might result from the outcome of these
uncertainties.

Income Taxes

We use the liability method of accounting for income taxes pursuant to
Statement of Financial Accounting Standards Board Opinion No. 109.
Under this method, deferred income taxes are recorded to reflect the
tax consequences in future periods of temporary differences between the
tax basis of assets and liabilities and their financial amounts at
year-end.

Earnings (loss) Per Common Share

Basic loss per common share has been calculated based upon the weighted
average number of common shares outstanding during the period in
accordance with the Statement of Financial Accounting Standards
Statement No. 128, "Earnings per Share".

Use of Estimates in the Preparation of Financial Statements

The preparation of financial statements in conformity with accounting
principles generally accepted in the United States of America requires
management to make estimates and assumptions that affect the reported
amounts of assets and liabilities, the disclosure of contingent assets
and liabilities at the date of the financial statements and the
reported amounts of revenues and expenses during the reporting periods.
Actual results could differ from those estimates and assumptions.

Fair Value of Financial Instruments

Statement of Financial Accounting Standards No. 107, disclosures about
fair value of financial instruments, defines the fair value of a
financial instrument as the amount at which the instrument could be
exchanged in a current transaction between willing parties. The

<PAGE>23

DULCIN IZMIR CORPORATION
(A Development Stage Company)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

carrying values of our financial instruments, which consists of
advances and accounts payable approximate fair values due to the short-
term maturities of such instruments.

Equipment

A telephone system purchased on August 18, 2006, is stated at cost.
Depreciation based on a 5 year useful life using the straight line
method is to commence September 1, 2006.  There was no depreciation
expense for either of the periods presented in consolidated operations
or cash flows.

NOTE 2 - CONTRIBUTED CAPITAL

Capital contributed during the year ended August 31, 2006, by current
management, was based on the fair value of such services which were for
office overhead of $3,250.

NOTE 3 - RELATED PARTY TRANSACTIONS

Accounts Payable - Related Party

As of August 31, 2006, Prosper Financial, Inc. (Prosper), a corporation
owned by the president of the Company who owns the majority of the
outstanding common stock of the Company was owed $4,237, which has been
reflected in accounts payable - related party in the accompanying
consolidated balance sheet, and the balance of $934 for accrued payroll
to the president. Prosper was paid $48,000 during the year ended August
31, 2006 for management services and $0 for the prior year.

Consulting Agreement - Related Party

A consulting agreement between Prosper and Dulcin, which was signed and
effective on September 1, 2005, includes but is not limited to payment
for services in the amount of $4,000 per month, reimbursement for all
reasonable expenses, and shall be in effect for one year from the
commencement of the agreement.  The agreement can be terminated by
Dulcin, with a 30 day notice.  The agreement was renewed for another
one year term effective on September 1, 2006.

NOTE 4 - INCOME TAXES

Because of the losses since inception, we have no income tax liability
or tax assets except deferred income tax assets. Deferred tax assets as
of August 31, 2006, of approximately $86,574 were reduced to zero,
after considering the valuation allowance of $86,574, since there is no
assurance of future taxable income at the present time. As of August
31, 2006 there was also a net operating loss carryforward of



<PAGE>24
DULCIN IZMIR CORPORATION
(A Development Stage Company)
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

approximately $254,630, of which $30,589 expires in 2025, and the
balance in 2026, if unused.  The following is an analysis of deferred
tax assets as of August 31, 2006:
<TABLE>
                                          Deferred         Valuation
                                         Tax Assets        Allowance        Balance
                                         ----------        ---------        -------

                                         <c>               <c>             <c>
Deferred tax assets at August 31, 2005    $ 10,400        $ ( 10,400)       $   -0-
Additions for the year                    $ 76,174        $ ( 76,174)       $   -0-
                                          --------        ----------        -------
Deferred tax assets at August 31, 2006    $ 86,574        $ ( 86,574)       $   -0-
                                          ========        ==========        =======
</TABLE>
The following is reconciliation from the expected statutory federal
income tax rate to the Company's actual income tax rate for the year
ended August 31:

                                              2006          2005
                                             ------        ------
Expected income tax (benefit) at
   federal statutory tax rate -34%        $( 77,502)     $( 10,845)
Permanent differences                         1,328            445
Valuation allowance                          76,174         10,400
                                          ---------      ---------
Income tax (benefit)                      $     -0-      $     -0-
                                          =========      =========
The net operating loss carryforward is the only component of deferred
tax assets as of August 31, 2006 and 2005.


NOTE 5 - COMMITMENTS AND CONTINGENCIES

Formation and Funding for Lifespan Health Sciences, Inc.

The provisions of the MOU underlying the formation of Lifespan include
consulting fees for Fairgrief, an investment schedule, and four phases
of a business plan as discussed below:

Upon the formation of Lifespan under Section 351 of the Internal
Revenue Code, Fairgrief will own 48% and Dulcin 52%.  If Dulcin does
not reach a total $2,000,000 by March 31, 2008, Fairgrief can buy
Lifespan at a sum equal to the amount invested by Dulcin plus 5% per
annum.

By December 31, 2006, Dulcin must invest $250,000 in Lifespan, and an
additional $150,000 by March 31, 2007, in order to maintain its initial
percentage ownership. Dulcin is required to invest an additional
$1,600,000 in Lifespan by March 31, 2008  At reaching this milestone,
Our equity will be 57.1.  Dulcin must invest an additional $3,000,000
by December 31, 2009 at which time the equity will be 62.1%for us.

<PAGE>25
DULCIN IZMIR CORPORATION
(A Development Stage Company)
NOTE TO CONSOLIDATED FINANCIAL STATEMENTS


There is a clause whereby Fairgrief will own the reciprocal
percentages, and if his equity falls below those percentages, Dulcin
will transfer sufficient shares to him.

The MOU also has provisions for compensation to Fairgrief in four
stages. In the first stage which commenced on July 1, 2006, Fairgrief
will be paid $6,000 per month, in phase 2 $7,000 per month, and in
phases 3 and 4, if Lifespan becomes profitable, $8,000 and $10,000,
respectively. As of August 31, 2006, Fairgrief was paid a total of
$12,000 prior to the incorporation of Lifespan for the two months then
ended.  As of August 31, 2006, no investment has been made by us into
Lifespan.

The MOU between the parties is a tentative agreement and was
subsequently finalized as further discussed in Note 13.
Lease of office space

We signed a one year lease renewal for office space in Miami, Florida
commencing on August 1, 2006, for a monthly rental of $963. Rent
expense for the year ended August 31, 2006, and period from inception
to August 31, 2005 was $6,700 and $1,239, respectively.

NOTE 6 - THE EFFECT OF RECENTLY ISSUED ACCOUNTING STANDARDS

Interpretation No. 46 (FIN 46) (R)

Effective December 2003, The Financial Accounting Standards Board
revised Fin 46 which required certain variable interest entities to be
consolidated by the primary beneficiary of the entity if the equity
investors in the entity did not have the characteristics of a
continuing financial interest or did not have sufficient equity at risk
for the entity to finance its activities without additional
subordinated financial support from other parties, the determination to
be made on the date an enterprise becomes involved with an entity.

SFAS 123 (R)

In December 2004, the FASB issued Statement of Financial Accounting
Standards ("SFAS") No. 123 (revised 2004), Share-Based Payment ("SFAS
No. 123-R"). SFAS No.123-R is a revision of SFAS No. 123, as amended,
Accounting for Stock-Based Compensation, and supersedes Accounting
Principles Board Opinion No. 25, Accounting for Stock Issued to
Employees. SFAS No.123-R eliminates the alternative to use the
intrinsic value method of accounting that was provided in SFAS No. 123,
which generally resulted in no compensation expense recorded in the
financial statements related to the issuance of equity awards to
employees. SFAS No. 123-R requires that the cost resulting from all
share-based payment transactions be recognized in the financial



<PAGE>26
DULCIN IZMIR CORPORATION
(A Development Stage Company)
NOTE TO CONSOLIDATED FINANCIAL STATEMENTS

statements. SFAS No. 123-R establishes fair value as the measurement
objective in accounting for share-based payment arrangements and
requires all companies to apply a fair-value-based measurement method
in accounting for generally all share-based payment transactions with
employees commencing in 2006.

The adoption of these new Statements is not expected to have a material
effect on the Company's financial position, results of operations, and
cash flows in future periods.


NOTE 7 - COMMON STOCK

In September and October 2005, we sold, in a private placement,
4,526,000 shares of common stock at $.05 per share, for gross proceeds
of $226,300, all of which was received by October 26, 2005. In June and
July 2006, we sold in a private placement, 37,500 shares of common stock
at $.40 per share, for gross proceeds of $15,000, all of which was
received by August 31, 2006. We are continuing to sell shares at this
price.  In June, July and August 2005, we sold, in a private placement,
1,474,000 shares of common stock at $.05 per share, for gross proceeds
of $73,700, less $38,000 for stock offering costs, for a net of $35,700
to us.


NOTE 8 - PUBLIC OFFERING OF COMMON STOCK

We registered, on form SB-2, 10,000,000 shares of common stock at $.25
per share, of which 6,000,000 shares were for the founding
shareholders. Form SB-2 became effective on March 31, 2006. As of
August 31, 2006, total stock registration costs of $10,294 were
incurred and have been reflected in the consolidated statements of
operations.


NOTE 9 - RESEARCH AND DEVELOPMENT

Research and Development (R&D) costs are being expensed as R&D when
incurred until technological feasibility is established. R&D is a
separate component of operating expense. Technological feasibility is
established upon completion of a working model, which is typically
demonstrated after initial beta testing is completed. Development costs
incurred subsequent to the time a product's technological feasibility
has been established, through the time the product is available for
general release to customers, are capitalized, if material.

The majority of incurred R&D as reported in the accompanying
consolidated financial statements related to the Blue Sky project which
was abandoned as of August 18, 2006 as further described in Note 11.



<PAGE>27


DULCIN IZMIR CORPORATION
(A Development Stage Company)
NOTE TO CONSOLIDATED FINANCIAL STATEMENTS

NOTE 10 - ACCOUNTING IRREGULARITY

The Company's internal controls were compromised by its bookkeeper
during the current year only, wherein the bookkeeper intentionally paid
herself $11,000 more than she had earned using pre-signed checks. This
amount was subsequently reduced to $9,000 by an offset of time she had
earned, and the reduced balance was repaid in full in July 2006, by
which date she was terminated. There was no resulting effect on
financial position or results of operations as of August 31, 2006, and
for the year then ended. A change in internal controls to preclude the
issuance of any further pre-signed checks was subsequently implemented
by management.


NOTE 11 - TERMINATION OF BLUE SKY AGREEMENT

We entered into a Memorandum of Understanding ("MOU") on August15,
2005, with Deleo, a Delaware Corporation, owner of a technology called
Catalytically Enhanced Engine Fuel Systems.  Under the MOU, we were to
purchase up to a 70% equity interest in Blue Sky International Ltd.
Deleo granted Blue Sky an exclusive, worldwide, non-royalty bearing
license to manufacture and market Deleo's engine devices. We were
unable to successfully complete a definitive material agreement
incorporating the terms of the MOU and formally terminated further
negotiations with Deleo and Blue Sky on August 18, 2006, leaving Blue
Sky with no interest or value in the technology.


NOTE 12 - IMPAIRMENT LOSS

On August 11, 2006, we loaned Reven Pharma Corp. (Reven) $50,000.
Since the loan was unsecured and not repaid as of August 31, 2006, or
subsequently, we had the alternative option of collateralizing the loan
with common stock of Reven or applying it towards an interest in an
application that Reven was developing.

Reven has not provided us with any financial information, nor has it
guaranteed the loan.  Therefore, we decided to impair the full amount
of the loan as of August 31, 2006, based on the present inability of
Reven to repay it, or provide sufficient information with which to
evaluate its collectibility or eventual recoverability.


NOTE 13 - SUBSEQUENT EVENTS

Consulting Agreement - Related Party

A consulting agreement between Prosper and Dulcin which was renewed on
September 1, 2006, includes but is not limited to, payment for services
in the amount of $4,000 per month, reimbursement for all reasonable

<PAGE>28
DULCIN IZMIR CORPORATION
(A Development Stage Company)
NOTE TO CONSOLIDATED FINANCIAL STATEMENTS

expenses, and shall be in effect for another year. This agreement can
be terminated by Dulcin, with a 30 day notice.

Amendment to Memorandum of Understanding with Fairgrief

On September 8, 2006, the parties signed an amendment to its MOU as
further described in Note 5.  In addition to the previously noted
points, the new agreement includes a provision to pay the president of
Dulcin a salary equal to two-thirds of Fairgrief's salary at any phase.
Upon execution of the amended agreement, we shall own 53% and Fairgrief
shall own 48% of shares issued (this is equal to a 1% change for each
party).  The remaining investment requirements and phases remain in
force.  The amendment also has provisions that Fairgrief will transfer
to Lifespan all rights and interests in the planned treatment program,
and that the agreement can be terminated by either party before the
date of a definitive agreement, and if terminated by Fairgrief, all
monies invested by Dulcin shall be returned within three business days.




<PAGE>29

(b)    List of Exhibits

The following exhibits are filed with this report:

  Exhibit 31 - 302 certification
  Exhibit 32 - 906 certification


 (B)    REPORTS ON FORM 8-K
    none

ITEM 14.  PRINCIPAL ACCOUNTANT FEES AND SERVICES.

Audit Fees.  We incurred aggregate fees and expenses of approximately
$14,750 from Braverman International, P.C. for the 2006 and 2005 fiscal
years.  Such fees included work completed for our annual audits and for
the review of our financial statements included in our Form 10-QSB.

Tax Fees. We did not incur any aggregate tax fees and expenses from
Braverman International, P.C.  for the 2006 fiscal year for
professional services rendered for tax compliance, tax advice, and tax
planning.

All Other Fees. We did not incur any other fees from Braverman
International, P.C. during fiscal 2006.  The board of directors, acting
as the Audit Committee considered whether, and determined that, the
auditor's provision of non-audit services was compatible with
maintaining the auditor's independence.  All of the services described
above for fiscal year 2006 were approved by the Board of Directors
pursuant to its policies and procedures.  We intend to continue using
Braverman International, P.C. solely for audit and audit-related
services, tax consultation and tax compliance services, and, as needed,
for due diligence in acquisitions.






<PAGE>30

                  SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities
Exchange Act of 1934, as amended, the Corporation has duly caused this
Report to be signed on its behalf by the undersigned duly authorized
person.

Date:    December 11, 2006

Dulcin Izmir Corporation

/s/ Maria Camila Maz
- ------------------------------
By: Maria Camila Maz, President

Pursuant to the requirements of the Securities Exchange Act of 1934, as
amended, this report has been signed below by the following persons on
behalf of the Corporation and in the capacities and on the dates
indicated.

By: /s/Maria Camila Maz                      Dated:  December 11, 2006
    Director, Chief Executive Officer
    Controller, Chief Financial Officer
    Director



               302 CERTIFICATION

I, Maria Camila Maz, certify that:

         1. I have reviewed the annual report on Form 10-KSB of Dulcin
Izmir Corporation;

         2. Based on my knowledge, this annual report does not contain
any untrue statement of a material fact or omit to state a material
fact necessary to make the statements made, in light of the
circumstances under which such statements were made, not misleading
with respect to the period covered by this report;

         3. Based on my knowledge, the financial statements, and other
financial information included in this annual report, fairly present in
all material respects the financial condition, results of operations
and cash flows of the registrant as of, and for, the periods presented
in this report;

         4. I am responsible for establishing and maintaining
disclosure controls and procedures (as defined in Exchange Act Rules
12a-14) and internal controls over financial reporting (as defined in
Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and
have:
      a)  designed such disclosure controls and procedures to ensure
that material information relating to the registrant, including its
consolidated subsidiaries, is made known to us by others within those
entities, particularly during the period in which this annual report is
being prepared;

      b) evaluated the effectiveness of the registrant's disclosure
controls and procedures as of a date within 90 days prior to the filing
date of this annual report (the "Evaluation Date"); and

      c)  presented in this annual report our conclusions about the
effectiveness  of the disclosure  controls and procedures based on our
evaluation as of the Evaluation Date;

         5. I have disclosed, based on our most recent evaluation, to
the registrant's auditors and the audit committee of registrant's board
of directors (or persons performing the equivalent functions):

         a) all significant deficiencies and material weaknesses in the
design or operation of internal control over financial reporting which
are reasonably likely to adversely affect the registrant's ability to
record, process, summarize and report financial information; and

         b) any fraud, whether or not material, that involves
management or other employees who have a significant role in the
registrant's internal controls over financial reporting.

Date: December 11, 2006            /s/Maria Camila Maz
                                   ----------------------------
                                   Maria Camila Maz
                                   Chief Executive Officer
                                   Chief Financial Officer





                             CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

The undersigned officer of Dulcin Izmir Corporation (the "Company"),
hereby certifies, to such officer's knowledge, that the Company's
Annual Report on Form 10-KSB for the year ended August 31, 2006 (the
"Report") fully complies with the requirements of Section 13(a) of the
Securities Exchange Act of 1934 and that the information contained in
the Report fairly presents, in all material respects, the financial
condition and results of operations of the Company.

                                 /s/Maria Camila Maz
                                 ----------------------
                                 Maria Camila Maz
                                 Chief Executive Officer
                                 Chief Financial Officer

December 11, 2006